The mission of Osteotronix is the development and commercialisation of our unique magnetic resonance-based diagnostic technique, Fine Structure Analysis (fineSA®) for the in-vivo characterisation of the spacing of anatomical structure on a fine scale. Changes in anatomical structures are associated with the early stages of a number of diseases.
Our patented software tools work as an add-on to existing magnetic resonance imaging hardware allowing the proprietary data to be acquired in as little as 16 seconds. The information is then analysed and returned as a report.
The acquisition tool, analysis system and display are all protected by patent.
The software has been cleared by the FDA for assessment of bone structure in the lumbar spine.
Osteotronix Ltd
The Life Sciences Hub 3 Assembly Square, Cardiff CF10 4PL, UK